Flexible, Suturable, and Leak-free Scaffolds for Vascular Tissue Engineering Using Melt Spinning.
Julia Fernández-PérezKenny A van KampenCarlos MotaMatthew B BakerLorenzo MoroniPublished in: ACS biomaterials science & engineering (2023)
Coronary artery disease affects millions worldwide. Bypass surgery remains the gold standard; however, autologous tissue is not always available. Hence, the need for an off-the-shelf graft to treat these patients remains extremely high. Using melt spinning, we describe here the fabrication of tubular scaffolds composed of microfibers aligned in the circumferential orientation mimicking the organized extracellular matrix in the tunica media of arteries. By variation of the translational extruder speed, the angle between fibers ranged from 0 to ∼30°. Scaffolds with the highest angle showed the best performance in a three-point bending test. These constructs could be bent up to 160% strain without kinking or breakage. Furthermore, when liquid was passed through the scaffolds, no leakage was observed. Suturing of native arteries was successful. Mesenchymal stromal cells were seeded on the scaffolds and differentiated into vascular smooth muscle-like cells (vSMCs) by reduction of serum and addition of transforming growth factor beta 1 and ascorbic acid. The scaffolds with a higher angle between fibers showed increased expression of vSMC markers alpha smooth muscle actin, calponin, and smooth muscle protein 22-alpha, whereas a decrease in collagen 1 expression was observed, indicating a positive contractile phenotype. Endothelial cells were seeded on the repopulated scaffolds and formed a tightly packed monolayer on the luminal side. Our study shows a one-step fabrication for ECM-mimicking scaffolds with good handleability, leak-free property, and suturability; the excellent biocompatibility allowed the growth of a bilayered construct. Future work will explore the possibility of using these scaffolds as vascular conduits in in vivo settings.
Keyphrases
- tissue engineering
- smooth muscle
- extracellular matrix
- transforming growth factor
- coronary artery disease
- endothelial cells
- poor prognosis
- stem cells
- high resolution
- ejection fraction
- minimally invasive
- type diabetes
- chronic kidney disease
- percutaneous coronary intervention
- mass spectrometry
- atrial fibrillation
- coronary artery bypass
- vascular smooth muscle cells
- long non coding rna
- aortic valve
- cell therapy
- left ventricular
- transcatheter aortic valve replacement
- solid state
- angiotensin ii
- current status